HUMPHREY RACHEL — SEC Form 4 filings

SEC reporting owner CIK 1579781. 4 Form 4 filings on record with FilingPulse; latest filed 2026-03-25.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-03-28 to 2026-03-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Pyxis Oncology, Inc. (PYXS)Director43 legs · 15,496 sh · $15,9173

Form 4 filings — HUMPHREY RACHEL

FiledFormIssuerReported transactionsSource
2026-03-254Pyxis Oncology, Inc. (PYXS)Sale (S): 1,400 @ $0.97 · Sale (S): 200 @ $0.97 · Sale (S): 13,896 @ $1.03EDGAR
2026-03-254Pyxis Oncology, Inc. (PYXS)Grant/award (A): 45,867 (derivative) @ $0EDGAR
2025-04-024Pyxis Oncology, Inc. (PYXS)Grant/award (A): 36,979 (derivative) @ $0.98EDGAR
2024-03-284Pyxis Oncology, Inc. (PYXS)Grant/award (A): 38,741 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579781 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →